Treatment with the phosphodiesterase type 4 inhibitor rolipram fails to inhibit blood brain barrier disruption in MS

Por Bielekova, Bibiana, Richert, Nancy, Howard, Thomas, Packer, Amy N., Blevins, Gregg, Ohayon, Joan, McFarland, Henry F., Stürzebecher, Claus-Steffen, Martin, Roland
Publicado em 2009